Clinical trial
Plasma, ELF and Intraperitoneal Pharmacokinetics of Ceftazidime/Avibactam in Critically Ill and Peritoneal Dialysis Patients
NCT03790176 is registered in ClinicalTrials.gov with Markus Zeitlinger as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Plasma, ELF and Intraperitoneal Pharmacokinetics of Ceftazidime/Avibactam in Critically Ill and Peritoneal Dialysis Patients
- Lead sponsor
- Markus Zeitlinger
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- October 1, 2018
- Completion date
- December 31, 2022
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.